Mycophenolic acid is an active metabolite of mycophenolate, a drug
An imunosuppressant administered primarily to patients after
transplants (heart, kidney, liver) as a means of preventing
transplant rejection. The drug is also sometimes given to patients
suffering from autoimmune diseases. Mycophenolic acid inhibits
inosine monophosphate dehydrogenase, which is involved in the synthesis of
guanosine nucleosides necessary for the construction of DNA. The patient
is usually given a standard dose of the drug; dose changes should be
monitored depending on clinical effects. Too low a concentration
can lead to graft rejection, too high can have a
toxic effects.